These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21203416)

  • 21. Recombinant fimbriae protein of Porphyromonas gingivalis induces an inflammatory response via the TLR4/NF‑κB signaling pathway in human peripheral blood mononuclear cells.
    Cai J; Chen J; Guo H; Pan Y; Zhang Y; Zhao W; Li X; Li Y
    Int J Mol Med; 2019 Mar; 43(3):1430-1440. PubMed ID: 30664173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
    Li CX; Su Y; Gong ZC; Liu H
    Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells.
    Ohno T; Yamamoto G; Hayashi JI; Nishida E; Goto H; Sasaki Y; Kikuchi T; Fukuda M; Hasegawa Y; Mogi M; Mitani A
    PLoS One; 2017; 12(9):e0184825. PubMed ID: 28934245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin G subclass antibody profiles in Porphyromonas gingivalis-associated aggressive and chronic periodontitis patients.
    Takeuchi Y; Aramaki M; Nagasawa T; Umeda M; Oda S; Ishikawa I
    Oral Microbiol Immunol; 2006 Oct; 21(5):314-8. PubMed ID: 16922931
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Cheng R; Liu W; Zhang R; Feng Y; Bhowmick NA; Hu T
    Front Cell Infect Microbiol; 2017; 7():474. PubMed ID: 29184853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation of human gingival epithelial cells and monocytes by Porphyromonas gingivalis fimbriae.
    Eskan MA; Hajishengallis G; Kinane DF
    Infect Immun; 2007 Feb; 75(2):892-8. PubMed ID: 17118977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes.
    Fan Q; Sims T; Sojar H; Genco R; Page RC
    Oral Microbiol Immunol; 2001 Jun; 16(3):144-52. PubMed ID: 11358536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants of Porphyromonas gingivalis lipopolysaccharide alter lipidation of autophagic protein, microtubule-associated protein 1 light chain 3, LC3.
    Blasi I; Korostoff J; Dhingra A; Reyes-Reveles J; Shenker BJ; Shahabuddin N; Alexander D; Lally ET; Bragin A; Boesze-Battaglia K
    Mol Oral Microbiol; 2016 Dec; 31(6):486-500. PubMed ID: 26452236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: alternations in Toll-like receptor 2 and 4 signaling pathway.
    Sun Y; Li H; Sun MJ; Zheng YY; Gong DJ; Xu Y
    Inflammation; 2014 Feb; 37(1):268-76. PubMed ID: 24132662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages.
    Hajishengallis G; Wang M; Harokopakis E; Triantafilou M; Triantafilou K
    Infect Immun; 2006 Oct; 74(10):5658-66. PubMed ID: 16988241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.
    Castro SA; Collighan R; Lambert PA; Dias IH; Chauhan P; Bland CE; Milic I; Milward MR; Cooper PR; Devitt A
    Cell Death Dis; 2017 Mar; 8(3):e2644. PubMed ID: 28252646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gingipain-dependent augmentation by Porphyromonas gingivalis of phagocytosis of Tannerella forsythia.
    Jung YJ; Jun HK; Choi BK
    Mol Oral Microbiol; 2016 Dec; 31(6):457-471. PubMed ID: 26434368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyromonas gingivalis induces murine macrophage foam cell formation.
    Qi M; Miyakawa H; Kuramitsu HK
    Microb Pathog; 2003 Dec; 35(6):259-67. PubMed ID: 14580389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between infection of different strains of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in subgingival plaque and clinical parameters in chronic periodontitis.
    Wu YM; Yan J; Chen LL; Gu ZY
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):121-31. PubMed ID: 17266188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo.
    Hajishengallis G; Shakhatreh MA; Wang M; Liang S
    J Immunol; 2007 Aug; 179(4):2359-67. PubMed ID: 17675497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porphyromonas gingivalis induces autophagy in THP-1-derived macrophages.
    Park MH; Jeong SY; Na HS; Chung J
    Mol Oral Microbiol; 2017 Feb; 32(1):48-59. PubMed ID: 26792079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients.
    Yang J; Wu J; Liu Y; Huang J; Lu Z; Xie L; Sun W; Ji Y
    PLoS One; 2014; 9(1):e86599. PubMed ID: 24466164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.
    Wilensky A; Tzach-Nahman R; Potempa J; Shapira L; Nussbaum G
    J Innate Immun; 2015; 7(2):127-135. PubMed ID: 25228314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis.
    Chen D; Nie M; Fan MW; Bian Z
    Pharmacology; 2008; 82(4):264-9. PubMed ID: 18849645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Porphyromonas gingivalis W83 FimA alters immune response and metabolic gene expression in oral squamous carcinoma cells.
    Groeger SE; Hudel M; Zechel-Gran S; Herrmann JM; Chakraborty T; Domann E; Meyle J
    Clin Exp Dent Res; 2022 Aug; 8(4):976-987. PubMed ID: 35570325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.